Evidence map›Paper›PMID 25378230›Full record

ArticleEuropean journal of immunology2015

Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis.

Aswin Hari, Anutosh Ganguly, Libing Mu, Shevaun P Davis, Melanie D Stenner, Raymond Lam, Fay Munro, Inana Namet, Enaam Alghamdi, Tobias Fürstenhaupt and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Characterization of CD8Journal of virology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Alum: an old dog with new tricks.Emerging microbes & infections · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Aswin HariDepartments of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.
Anutosh Ganguly
Libing Mu
Shevaun P Davis
Melanie D Stenner
Raymond Lam
Fay Munro
Inana Namet
Enaam Alghamdi
Tobias Fürstenhaupt
Wei Dong
Pascal Detampel
Lian Jun Shen
Matthias W Amrein
Robin M Yates
Yan Shi
University of Calgary · CACenter for Life Sciences · CNTsinghua University · CNUniversity of Massachusetts Chan Medical School · US

Funding

Adjuvants' mechanismsR01AI098995 · NIAID · UNIVERSITY OF CALGARY · PI SHI, YAN · 2012 to 2016
$1.0M
Alum's adjuvanticityR21AI089963 · NIAID · UNIVERSITY OF CALGARY · PI SHI, YAN · 2010 to 2011
$295k
Canadian Institutes of Health Research MOP-119295NIAID NIH HHS R01 AI098995NIAID NIH HHS R01AI098995NIAID NIH HHS R21 AI089963NIAID NIH HHS R21AI089963
6 · The paper itself

Abstract

Peptides presented by MHC class I molecules are mostly derived from proteins synthesized by the antigen-presenting cell itself, while peptides presented by MHC class II molecules are predominantly from materials acquired by endocytosis. External antigens can also be presented by MHC class I molecules in a process referred to as cross-presentation. Here, we report that mouse dendritic cell (DC) engagement to a phagocytic target alters endocytic processing and inhibits the proteolytic activities. During phagocytosis, endosome maturation is delayed, shows less progression toward the lysosome, and the endocytosed soluble antigen is targeted for MHC class I cross-presentation. The antigen processing in these arrested endosomes is under the control of NAPDH oxidase associated ROS. We also show that cathepsin S is responsible for the generation of the MHC class I epitope. Taken together, our results suggest that in addition to solid structure uptake, DC phagocytosis simultaneously modifies the kinetics of endosomal trafficking and maturation. As a consequence, external soluble antigens are targeted into the MHC class I cross-presentation pathway.

Indexed as

Antigen PresentationCross-PrimingPhagocytosisAnimalsCathepsinsDendritic CellsEndocytosisEndosomesEpitopesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIInflammationLysosomesMiceMice, KnockoutMultienzyme Complexescathepsin SCathepsinsEpitopesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMultienzyme ComplexesNADH, NADPH OxidoreductasesNADH oxidaseOvalbuminReactive Oxygen SpeciesAntigen processing · Cross-presentation · Dendritic cells · MHC class I · Phagocytosis

Identifiers

PMID25378230
PMCPMC4324331
OpenAlexW1893872461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.